|
[BACK]
Pediatric Influenza Immunization Dosing Guidelines
Recommended dosing by patient age and Fluzone vaccine presentation1,2
Age Group |
Dosage |
Formulation |
# Doses |
Route* |
CPT®†Code |
6-35 months |
0.25mL |
Fluzone Vaccine,
No Preservative:
Pediatric Dose
prefilled syringes |
1 or 2‡ |
Intramuscular |
90655 |
36 months and older |
0.50mL |
Fluzone Vaccine,
No Preservative:
prefilled syringes |
1 or 2‡ |
Intramuscular |
90656 |
6-35 months |
0.25mL |
Fluzone Vaccine
Multi-dose vials |
1 or 2‡ |
Intramuscular |
90657 |
3-8 years |
0.50mL |
Fluzone Vaccine
Multi-dose vials |
1 or 2‡ |
Intramuscular |
90658 |
> 9 years |
0.50mL |
Fluzone Vaccine
Multi-dose vials |
1 |
Intramuscular |
* For older children, the recommended site of vaccination is the deltoid muscle. The preferred site for infants and young children is the anterolateral aspect of the thigh.
† CPT is a registered trademark of the American Medical Association.
‡ Two doses administered at least one month apart are recommended for children <9 years of age who are receiving influenza vaccine for the first time.
Number of doses
- 2 doses, administered at least 1 month apart are recommended for children <9 years of age who are receiving influenza vaccine for the first time. If possible, 2nd dose should be administered before December1
Route of administration
-
Fluzone vaccine is administered as an intramuscular injection 1
- The preferred site for infants and young children is the anterolateral aspect of the thigh1
- For older children and adults, the deltoid muscle is the preferred site1
How many doses of Fluzone vaccine will your practice need?
Indication
Fluzone vaccine is indicated for active immunization in persons 6 months of age and older against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine.
Safety Information
The most common local and systemic adverse reactions to Fluzone vaccine include soreness, pain, and swelling at the vaccination site; fever, malaise, and myalgia. Other adverse reactions may occur. Influenza vaccine should not be administered to anyone with a history of hypersensitivity to any vaccine component, including eggs, egg products, or thimerosal (the only presentation that contains thimerosal is the multi-dose vial). Fluzone vaccine should not be administered to individuals who have a prior history of Guillain-Barré syndrome (GBS). Vaccination with Fluzone vaccine may not protect all individuals.
Before administering Fluzone vaccine, please see accompanying full Prescribing Information.
[BACK] |